Skip to main content

BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th

VANCOUVER, British Columbia and REHOVOT, Israel, Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) the global leader in Botanical Synthesis focused on growing plant cells without growing the plant, announces that Ilan Sobel, CEO, will present live at the Life Science Investor Forum, hosted by, today, December 14th, 2023

DATE: December 14th, 2023
TIME: 12:30 PM ET
Available for 1x1 meetings: December 14, 15, 18

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at

Recent Company Highlights

  • Q3 Subscriber and Revenue Growth is Further Validation of the Botanical Synthesis Technology Platform
  • High revenue growth - Q4 2023 corporate revenue range guidance of USD 4.2M – 4.5M, 30%+ growth from Q3 2023
  • Launched new SuperFood VINIA coffees on December 13, 2023, aiming to disrupt the $6B US coffee pod market
  • New Functional Coffees are First of three Major “VINIA Inside” Products to be Launched

About BioHarvest Sciences

BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself. BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals - nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API's) that focus on specific medical indications.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

BioHarvest Sciences
Justin Meiklem
Investor Relations

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.